IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Latest 10-K405/A SEC Filings
Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]

NEOPROBE CORP, 10-K405/A, 2000-08-07
MERIDIAN DIAGNOSTICS INC, 10-K405/A, 2000-08-07
OSTEX INTERNATIONAL INC /WA/, 10-K405/A, 2000-04-14
GENOME THERAPEUTICS CORP, 10-K405/A, 2000-02-15
AVIGEN INC \DE, 10-K405/A, 2000-02-11
OSTEX INTERNATIONAL INC /WA/, 10-K405/A, 1999-04-01
AQUILA BIOPHARMACEUTICALS INC, 10-K405/A, 1998-10-02
IMMUCOR INC, 10-K405/A, 1998-08-20
ONCOR INC, 10-K405/A, 1998-05-22
IDEXX LABORATORIES INC /DE, 10-K405/A, 1998-05-20
CHEMTRAK INC/DE, 10-K405/A, 1998-05-12
DYNAGEN INC, 10-K405/A, 1998-04-16
CHEMTRAK INC/DE, 10-K405/A, 1998-04-13
EPITOPE INC/OR/, 10-K405/A, 1998-02-05
ABAXIS INC, 10-K405/A, 1997-10-28
OSTEX INTERNATIONAL INC /WA/, 10-K405/A, 1997-10-17
INCSTAR CORP, 10-K405/A, 1997-05-19
METRA BIOSYSTEMS INC, 10-K405/A, 1996-10-31
ADVANCED MAGNETICS INC, 10-K405/A, 1996-01-11


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission